ridm@nrct.go.th   ระบบคลังข้อมูลงานวิจัยไทย   รายการโปรดที่คุณเลือกไว้

Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats

หน่วยงาน มหาวิทยาลัยเชียงใหม่

รายละเอียด

ชื่อเรื่อง : Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats
นักวิจัย : Tanajak P. , Sa-Nguanmoo P. , Wang X. , Liang G. , Li X. , Jiang C. , Chattipakorn S. , Chattipakorn N.
คำค้น : -
หน่วยงาน : มหาวิทยาลัยเชียงใหม่
ผู้ร่วมงาน : -
ปีพิมพ์ : 2559
อ้างอิง : 17481708 , 2-s2.0-84979021421 , 10.1111/apha.12698 , https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84979021421&origin=inward , http://cmuir.cmu.ac.th/jspui/handle/6653943832/41683
ที่มา : -
ความเชี่ยวชาญ : -
ความสัมพันธ์ : -
ขอบเขตของเนื้อหา : -
บทคัดย่อ/คำอธิบาย :

© 2016 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd Fibroblast growth factor 21 (FGF21) acts as a metabolic regulator and exerts cardioprotective effects. However, the effects of long-term FGF21 administration on the heart under the FGF21-resistant condition in obese, insulin-resistant rats have not been investigated. We hypothesized that long-term FGF21 administration reduces FGF21 resistance and insulin resistance and attenuates cardiac dysfunction in obese, insulin-resistant rats. Methods: Eighteen rats were fed on either a normal diet (n=6) or a high-fat diet (HFD; n=12) for 12weeks. Then, rats in the HFD group were divided into two subgroups (n=6 per subgroup) and received either the vehicle (HFV) or recombinant human FGF21 (rhFGF21, 0.1mgkg −1 day −1 ; HFF) injected intraperitoneally for 28days. The metabolic parameters, inflammation, malondialdehyde (MDA), heart rate variability (HRV), left ventricular (LV) function, cardiac mitochondrial redox homoeostasis, cardiac mitochondrial fatty acid β-oxidation (FAO) and anti-apoptotic signalling pathways were determined. Results: HFV rats had increased dyslipidaemia, insulin resistance, plasma FGF21 levels, TNF-α, adiponectin and MDA, depressed HRV, and impaired LV and mitochondrial function. HFV rats also had decreased cardiac Bcl-2, cardiac PGC-1α and CPT-1 protein expression. However, FGF21 restored metabolic parameters, decreased TNF-α and MDA, increased serum adiponectin, and improved HRV, cardiac mitochondrial and LV function in HFF rats. Moreover, HFF rats had increased cardiac Bcl-2, cardiac PGC-1α and CPT-1 protein expression. Conclusion: Long-term FGF21 therapy attenuates FGF21 resistance and insulin resistance and exerts cardioprotection by improving cardiometabolic regulation via activating anti-apoptotic and cardiac mitochondrial FAO signalling pathways in obese, insulin-resistant rats.

บรรณานุกรม :
Tanajak P. , Sa-Nguanmoo P. , Wang X. , Liang G. , Li X. , Jiang C. , Chattipakorn S. , Chattipakorn N. . (2559). Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats.
    เชียงใหม่ : มหาวิทยาลัยเชียงใหม่ .
Tanajak P. , Sa-Nguanmoo P. , Wang X. , Liang G. , Li X. , Jiang C. , Chattipakorn S. , Chattipakorn N. . 2559. "Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats".
    เชียงใหม่ : มหาวิทยาลัยเชียงใหม่ .
Tanajak P. , Sa-Nguanmoo P. , Wang X. , Liang G. , Li X. , Jiang C. , Chattipakorn S. , Chattipakorn N. . "Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats."
    เชียงใหม่ : มหาวิทยาลัยเชียงใหม่ , 2559. Print.
Tanajak P. , Sa-Nguanmoo P. , Wang X. , Liang G. , Li X. , Jiang C. , Chattipakorn S. , Chattipakorn N. . Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats. เชียงใหม่ : มหาวิทยาลัยเชียงใหม่ ; 2559.